KeyBank National Association’s AbbVie ABBV Stock Holding History

KeyBank National Association’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249M	Buy	1,146,641 +93,584	+9%	+$20.8M	0.91%	24
2025 Q4	$241M	Buy	1,053,057 +8,229	+0.8%	+$1.87M	0.86%	22
2025 Q3	$242M	Sell	1,044,828 -6,943	-0.7%	-$1.41M	0.85%	22
2025 Q2	$195M	Sell	1,051,771 -9,162	-0.9%	-$1.7M	0.73%	25
2025 Q1	$222M	Buy	1,060,933 +226,926	+27%	+$44.1M	0.89%	21
2024 Q4	$148M	Sell	834,007 -6,446	-0.8%	-$1.19M	0.57%	33
2024 Q3	$166M	Sell	840,453 -8,280	-1%	-$1.55M	0.64%	30
2024 Q2	$146M	Sell	848,733 -509	-0.1%	-$84.3K	0.6%	31
2024 Q1	$155M	Sell	849,242 -9	-0%	-$1.55K	0.64%	29
2023 Q4	$132M	Sell	849,251 -4,989	-0.6%	-$727K	0.58%	34
2023 Q3	$127M	Sell	854,240 -14,412	-2%	-$2.12M	0.61%	38
2023 Q2	$117M	Sell	868,652 -12,025	-1%	-$1.76M	0.53%	44
2023 Q1	$140M	Sell	880,677 -30,890	-3%	-$4.72M	0.67%	35
2022 Q4	$147M	Sell	911,567 -7,897	-0.9%	-$1.21M	0.72%	31
2022 Q3	$123M	Sell	919,464 -929	-0.1%	-$133K	0.64%	33
2022 Q2	$141M	Sell	920,393 -15,226	-2%	-$2.33M	0.69%	31
2022 Q1	$152M	Sell	935,619 -24,643	-3%	-$3.58M	0.64%	36
2021 Q4	$130M	Sell	960,262 -7,549	-0.8%	-$892K	0.52%	48
2021 Q3	$104M	Sell	967,811 -4,781	-0.5%	-$546K	0.45%	54
2021 Q2	$110M	Sell	972,592 -18,284	-2%	-$2.06M	0.48%	50
2021 Q1	$107M	Sell	990,876 -13,829	-1%	-$1.48M	0.5%	49
2020 Q4	$108M	Sell	1,004,705 -19,843	-2%	-$1.91M	0.53%	44
2020 Q3	$89.7M	Sell	1,024,548 -10,699	-1%	-$1.01M	0.49%	54
2020 Q2	$102M	Sell	1,035,247 -10,052	-1%	-$885K	0.59%	44
2020 Q1	$79.6M	Sell	1,045,299 -24,437	-2%	-$2.08M	0.53%	49
2019 Q4	$94.7M	Sell	1,069,736 -12,468	-1%	-$1.04M	0.51%	50
2019 Q3	$81.9M	Sell	1,082,204 -62,582	-5%	-$4.29M	0.47%	54
2019 Q2	$83.2M	Sell	1,144,786 -33,816	-3%	-$2.66M	0.48%	52
2019 Q1	$95M	Sell	1,178,602 -70,010	-6%	-$5.73M	0.57%	47
2018 Q4	$115M	Sell	1,248,612 -31,468	-2%	-$2.77M	0.75%	28
2018 Q3	$121M	Sell	1,280,080 -10,986	-0.9%	-$1.04M	0.67%	31
2018 Q2	$120M	Sell	1,291,066 -7,068	-0.5%	-$690K	0.7%	28
2018 Q1	$123M	Sell	1,298,134 -14,234	-1%	-$1.56M	0.73%	26
2017 Q4	$127M	Sell	1,312,368 -33,232	-2%	-$3.13M	0.73%	27
2017 Q3	$120M	Sell	1,345,600 -4,436	-0.3%	-$338K	0.71%	30
2017 Q2	$97.9M	Sell	1,350,036 -2,560	-0.2%	-$172K	0.59%	43
2017 Q1	$88.1M	Sell	1,352,596 -10,388	-0.8%	-$653K	0.53%	49
2016 Q4	$85.3M	Sell	1,362,984 -14,661	-1%	-$895K	0.53%	43
2016 Q3	$86.9M	Buy	1,377,645 +38,889	+3%	+$2.52M	0.55%	47
2016 Q2	$82.9M	Sell	1,338,756 -454	-0%	-$27.7K	0.54%	45
2016 Q1	$76.5M	Buy	1,339,210 +32,900	+3%	+$1.83M	0.51%	48
2015 Q4	$77.4M	Sell	1,306,310 -9,524	-0.7%	-$549K	0.52%	45
2015 Q3	$71.6M	Buy	1,315,834 +4,878	+0.4%	+$318K	0.51%	47
2015 Q2	$88.1M	Sell	1,310,956 -2,902	-0.2%	-$189K	0.59%	42
2015 Q1	$76.9M	Buy	1,313,858 +53,389	+4%	+$3.23M	0.5%	47
2014 Q4	$82.5M	Sell	1,260,469 -548	-0%	-$34.5K	0.54%	46
2014 Q3	$72.8M	Buy	1,261,017 +42,022	+3%	+$2.33M	0.5%	49
2014 Q2	$68.8M	Sell	1,218,995 -8,904	-0.7%	-$467K	0.46%	52
2014 Q1	$63.1M	Sell	1,227,899 -7,678	-0.6%	-$388K	0.49%	53
2013 Q4	$65.3M	Buy	1,235,577 +8,326	+0.7%	+$409K	0.43%	57
2013 Q3	$54.9M	Sell	1,227,251 -52,152	-4%	-$2.31M	0.38%	63
2013 Q2	$52.9M	Buy	+1,279,403	New	+$56M	0.2%	114

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KeyBank National Association's ABBV Position: Q1 2026 in Review

KeyBank National Association increased its AbbVie (ABBV) stake by 8.9% in Q1 2026, buying an estimated $20.8M and bringing the position to 1,146,641 shares worth $249M. The position accounts for 0.91% of the portfolio, ranked #24.

KeyBank National Association first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

KeyBank National Association held 1,146,641 shares of AbbVie worth $249M as of Q1 2026.
KeyBank National Association bought 93,584 AbbVie shares in Q1 2026, an estimated $20.8M.
AbbVie made up 0.91% of KeyBank National Association's portfolio in Q1 2026, its #24 holding.
KeyBank National Association first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on KeyBank National Association's 13F filing for Q1 2026, filed 24 Apr 2026.